Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer
Dushyanthen, Sathana, Teo, Zhi Ling, Caramia, Franco, Savas, Peter, Mintoff, Christopher P., Virassamy, Balaji, Henderson, Melissa A., Luen, Stephen J., Mansour, Mariam, Kershaw, Michael H., Trapani,Volume:
8
Language:
english
Journal:
Nature Communications
DOI:
10.1038/s41467-017-00728-9
Date:
December, 2017
File:
PDF, 2.25 MB
english, 2017